Global Allergy Immunotherapy Market

Global Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment Type(Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), By Allergy Type(Allergic Rhinitis, Asthma), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031


Report ID: SQSG35I2019 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 92 | Figures: 76

Global Allergy Immunotherapy Market Insights

Allergy Immunotherapy Market size was valued at USD 2.4 billion in 2019 and is poised to grow from USD 2.65 billion in 2023 to USD 4.9 billion by 2031, growing at a CAGR of 10.8% in the forecast period (2024-2031).

According to the World Allergy Organization, approximately 10-30% of the global population is currently suffering from different kinds of allergies. Allergy is the body's immune system being overly sensitive to certain substances, such as a particular meal, pollen, fur, or dust. Allergies come in many forms, including those to food, dust, pollen, latex, medications, and others. In order to build antibodies against the allergens, the body is exposed to small amounts of allergies during allergy immunotherapy. Immunotherapy uses regular, low-dose exposure to particular allergens to help the body adjust to their presence, resulting in effective and prompt allergy treatment.

The primary factors propelling the global market for allergy immunotherapy are the expansion of industrialization and population, improvements in healthcare and medicine, and the launch of new immunotherapeutic medications. To increase the market share of the global allergy immunotherapy market, recent regulatory approvals, such as those for oral dissolvable tablets, are further enhanced.

US Allergy Immunotherapy Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 2.4 billion

Largest Segment

Sublingual Immunotherapy (SLIT)

Fastest Growth

Sublingual Immunotherapy (SLIT)

Growth Rate

10.8% CAGR

Global Allergy Immunotherapy Market 2022-2028 ($ Bn)
Country Share for Europe Region- 2021 (%)
Global Allergy Immunotherapy Market Size By Treatment Type 2022-2028 ($ Bn)
Global Allergy Immunotherapy Market Size By Treatment Type 2022-2028 (%)

To get more reports on the above market click here to Buy The Report

Global Allergy Immunotherapy Market Segmental Analysis

The Global Allergy Immunotherapy Market is segmented based on treatment type, allergy type, distribution channel and region. Based on the Treatment Type, it is categorized into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Oral Allergy Immunotherapy. Based on Allergy Type, it is categorized into Allergic Rhinitis, Asthma, Food Allergy, and Drug Allergy. Based on the Distribution Channel, it is categorized into Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies. Based on region, it is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.

Allergy Immunotherapy Market Analysis by Treatment Type

On the basis of treatment type, the Sublingual Immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market over the forecast period. This is because it is the most efficient and popular type of allergen immunotherapy. Asthma, stinging insect hypersensitivity, and allergic rhinitis can all be effectively treated with this therapy. Additionally, SCIT has shown success in managing a variety of allergens. As a result, SCIT is more widely adopted than SLIT.

The segment for sublingual immunotherapy (SLIT) is anticipated to have the quickest CAGR throughout the projection period. For individuals who cannot receive allergy injections, SLIT is anticipated to become an essential option. SLIT pills that have received FDA approval and are currently available in the United States include Odactra, Grazax, Oralair, and Ragwitek. In the future, it is anticipated that liquid formulation will also be authorized for therapeutic use in the United States. This would accelerate the development of the SLIT market in the nation.

Allergy Immunotherapy Market Analysis by Distribution Channel

On the basis of distribution channel, the hospital pharmacy segment is expected to dominate the global allergy immunotherapy market over the forecast period. This is due to an increase in the number of patients seeking treatment for allergic disorders. In order to monitor and treat any negative responses, allergy injections are typically administered in medical facilities or doctor's offices. This accelerates the segment's growth even more. In order to increase the use of the therapy, medical facilities in Belgium have suggested setting up a national registry for allergen immunotherapy in hospitals and clinics. Additionally, after a few months of therapy, SLIT can be taken at home and the medications can be ordered online.

Global Allergy Immunotherapy Market By Treatment Type, 2021 (%), 2019 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Allergy Immunotherapy Market Regional Insights

Based on the region, the European region currently dominates the global allergy immunotherapy market with respect to market share, and it is projected that it will continue to hold a sizable share of the market throughout the forecast period. Due to high awareness, increased financing for research and grants, medical reimbursement rules, the rise in the population with allergies, and other factors, Europe was reported to hold the largest share of the worldwide allergy immunotherapy market. According to the European Academy of Allergy and Clinical Immunology (EAACI), 20 percent of the population in the area currently experiences chronic food allergies, which affect over 150 million people.

Asthma and allergic rhinitis are the most prevalent allergens, affecting 100 million and 70 million individuals, respectively. Furthermore, according to the organization, by 2025, 50 percent of the people in Europe would suffer from allergies, opening up a huge market for allergy immunotherapy.

The prevalence of allergies in Europe is also becoming a significant economic burden as a result of the ensuing productivity losses in European countries. In response to these issues, European governments and organizations, such as EAACI, are trying to increase public awareness and urge for better medical education and treatments, which will help the market in the area flourish.

Global Allergy Immunotherapy Market By Geography, 2022-2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Allergy Immunotherapy Market Dynamics

Allergy Immunotherapy Market Drivers

  • Increasing allergy cases to support the growth of allergy immunotherapy market: The rising prevalence of diverse allergies and the introduction of innovative sublingual immunotherapies in developing nations are the main drivers of market expansion for allergy immunotherapy. In the United States, allergies are the sixth most common chronic illness, costing more than USD 18 billion annually, and affect more than 50 million people, according to data from the American College of Allergy, Asthma & Immunology. Food allergies are becoming more common among both children and adults worldwide. Therefore, it is anticipated that the demand for innovative immunotherapies will be aided by the growing burden of allergic illnesses.

Allergy Immunotherapy Market Restraints

  • The newest technology available on the market, the allergy immunotherapy, requires routine maintenance. Due to the particular need for professional staff in the process, the cost of routine maintenance is relatively expensive. The system's operational costs will consequently rise as a result of this. This is the key cause or element that is projected to seriously hamper the global allergy immunotherapy market. Additionally, there is a need to raise knowledge about this microgrid management system across the many businesses, since this factor's ignorance of new technical breakthroughs could prove to be a barrier to the market's expansion for these systems.

Request Free Customization of this report to help us to meet your business objectives.

Global Allergy Immunotherapy Market Competitive Landscape

Key players in the market are focusing on creating therapies for food allergies in particular by taking advantage of the rising prevalence of allergies. They are funding R&D initiatives in an effort to accomplish the same. To keep ahead of the curve, a number of firms are concentrating on creating new goods, including tablets and injections.

Allergy Immunotherapy Market Top Players Company Profiles

  • ALK Abello
  • Allergy Therapeutics
  • Anergis SA
  • ASIT biotech
  • DBV Technologies
  • HAL Allergy Group
  • Hymenoptera Immunotherapy Group
  • Immunomic Therapeutics, Inc.
  • Laboratorios LETI
  • Merck KGaA
  • Novartis International AG
  • Stallergenes Greer plc
  • Tunitas Therapeutics, Inc.
  • VentiRx Pharmaceuticals
  • Biomay AG
  • Genentech, Inc.
  • GlaxoSmithKline plc
  • Meda AB
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.

Global Allergy Immunotherapy Key Market Trends

  • Technology advancements in high-resolution analysis of rare cells in local tissues have led to the emergence of precise and reliable biomarkers for allergy immunotherapy monitoring.
  • In addition to immunoglobulin and T-cell receptor transcript repertoires, genome-wide epigenetic alterations offer a source of novel biomarkers for allergy immunotherapy surveillance.
  • Using advanced multi-parameter flow and mass cytometry, rare, antigen-specific immune cells can be quantified and immuno-phenotyped in order to track the allergy immunotherapy.

Global Allergy Immunotherapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to the analysis, the global allergy immunotherapy market is currently led by countries in the European region, due to high awareness, and increased financing for research and grants in the region. Along with this, the sublingual immunotherapy (SLIT) segment is projected to dominate the global allergy immunotherapy market, due its high efficiency and popularity in the allergen immunotherapy market.

Report Metric Details
Market size value in 2019 USD 2.4 billion
Market size value in 2031 USD 4.9 billion
Growth Rate 10.8%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Treatment Type
    • Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), Oral Allergy Immunotherapy
  • Allergy Type
    • Allergic Rhinitis, Asthma, Food Allergy, Drug Allergy
  • Distribution Channel
    • Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • ALK Abello
  • Allergy Therapeutics
  • Anergis SA
  • ASIT biotech
  • DBV Technologies
  • HAL Allergy Group
  • Hymenoptera Immunotherapy Group
  • Immunomic Therapeutics, Inc.
  • Laboratorios LETI
  • Merck KGaA
  • Novartis International AG
  • Stallergenes Greer plc
  • Tunitas Therapeutics, Inc.
  • VentiRx Pharmaceuticals
  • Biomay AG
  • Genentech, Inc.
  • GlaxoSmithKline plc
  • Meda AB
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Allergy Immunotherapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Allergy Immunotherapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Allergy Immunotherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Allergy Immunotherapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Allergy Immunotherapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Allergy Immunotherapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Allergy Immunotherapy Market size was valued at USD 2.4 billion in 2019 and is poised to grow from USD 2.65 billion in 2023 to USD 4.9 billion by 2031, growing at a CAGR of 10.8% in the forecast period (2024-2031).

Key players in the market are focusing on creating therapies for food allergies in particular by taking advantage of the rising prevalence of allergies. They are funding R&D initiatives in an effort to accomplish the same. To keep ahead of the curve, a number of firms are concentrating on creating new goods, including tablets and injections. 'ALK Abello', 'Allergy Therapeutics', 'Anergis SA', 'ASIT biotech', 'DBV Technologies', 'HAL Allergy Group', 'Hymenoptera Immunotherapy Group', 'Immunomic Therapeutics, Inc.', 'Laboratorios LETI', 'Merck KGaA', 'Novartis International AG', 'Stallergenes Greer plc', 'Tunitas Therapeutics, Inc.', 'VentiRx Pharmaceuticals', 'Biomay AG', 'Genentech, Inc.', 'GlaxoSmithKline plc', 'Meda AB', 'Pfizer Inc.', 'Regeneron Pharmaceuticals, Inc.'

Increasing allergy cases to support the growth of allergy immunotherapy market: The rising prevalence of diverse allergies and the introduction of innovative sublingual immunotherapies in developing nations are the main drivers of market expansion for allergy immunotherapy. In the United States, allergies are the sixth most common chronic illness, costing more than USD 18 billion annually, and affect more than 50 million people, according to data from the American College of Allergy, Asthma & Immunology. Food allergies are becoming more common among both children and adults worldwide. Therefore, it is anticipated that the demand for innovative immunotherapies will be aided by the growing burden of allergic illnesses.

Technology advancements in high-resolution analysis of rare cells in local tissues have led to the emergence of precise and reliable biomarkers for allergy immunotherapy monitoring.

Based on the region, the European region currently dominates the global allergy immunotherapy market with respect to market share, and it is projected that it will continue to hold a sizable share of the market throughout the forecast period. Due to high awareness, increased financing for research and grants, medical reimbursement rules, the rise in the population with allergies, and other factors, Europe was reported to hold the largest share of the worldwide allergy immunotherapy market. According to the European Academy of Allergy and Clinical Immunology (EAACI), 20 percent of the population in the area currently experiences chronic food allergies, which affect over 150 million people.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Allergy Immunotherapy Market

Product ID: SQSG35I2019

$5,300
BUY NOW GET FREE SAMPLE